No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs554214903 |
chr4:165858311-165858312 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs372277054 |
chr4:165858319-165858320 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs111538142 |
chr4:165858362-165858363 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs371424749 |
chr4:165858363-165858364 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs148420824 |
chr4:165858371-165858372 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs59990883 |
chr4:165858373-165858374 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs112093584 |
chr4:165858432-165858433 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs201728034 |
chr4:165858452-165858453 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs34889570 |
chr4:165858456-165858457 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs76492527 |
chr4:165858457-165858458 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs397791653 |
chr4:165858471-165858472 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs201194973 |
chr4:165858473-165858474 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs369528399 |
chr4:165858501-165858502 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs565059700 |
chr4:165858537-165858538 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs532429546 |
chr4:165858556-165858557 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs548324574 |
chr4:165858590-165858591 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs374068878 |
chr4:165858620-165858621 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs540929491 |
chr4:165858648-165858649 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs568408175 |
chr4:165858665-165858666 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs376883786 |
chr4:165858683-165858684 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs200302683 |
chr4:165858685-165858686 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs369056154 |
chr4:165858697-165858698 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs73871541 |
chr4:165858721-165858722 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs10001924 |
chr4:165858728-165858729 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs35744224 |
chr4:165858740-165858741 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs531159331 |
chr4:165858746-165858747 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs144421205 |
chr4:165858782-165858783 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs55788652 |
chr4:165858788-165858789 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs535333313 |
chr4:165858795-165858796 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs79055863 |
chr4:165858869-165858870 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs570719379 |
chr4:165858884-165858885 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs79480092 |
chr4:165858910-165858911 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs59310432 |
chr4:165858962-165858963 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs535811398 |
chr4:165858980-165858981 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs148433612 |
chr4:165858995-165858996 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs186689160 |
chr4:165859008-165859009 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs55688693 |
chr4:165859016-165859017 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs141667461 |
chr4:165859020-165859021 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs558726903 |
chr4:165859027-165859028 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs189535854 |
chr4:165859038-165859039 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs576700020 |
chr4:165859060-165859061 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs541339303 |
chr4:165859106-165859107 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs6814451 |
chr4:165859117-165859118 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs183331022 |
chr4:165859154-165859155 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs369299172 |
chr4:165859166-165859167 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs542225430 |
chr4:165859197-165859198 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs140958573 |
chr4:165859233-165859234 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs542475810 |
chr4:165859249-165859250 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs531015806 |
chr4:165859299-165859300 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs116755535 |
chr4:165859318-165859319 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|